
High cost of new cancer drugs in US not related to their effectiveness, study shows
The high costs of recently licensed cancer medicines in the United States—as compared with those…
The high costs of recently licensed cancer medicines in the United States—as compared with those…
Neelakshi Mungra, University of Cape Town; Krupa Naran, University of Cape Town, and Trishana Nundalall…
The winners of this year’s Nobel Prize for Medicine say they expect substantial advances toward…
Richard De Abreu Lourenco, University of Technology Sydney; Marion Haas, University of Technology Sydney, and…
By Peter Gilbar for oncologynews.com.au The Problem Spending on cancer drugs is increasing at a…